Glycemic control and self-monitoring of blood glucose in Chinese patients with type 2 diabetes on insulin: Baseline results from the COMPASS study

Diabetes Research and Clinical Practice

Volumn 112, Issue , 2016, Pages 82-87

  Ji, L ^a   Su, Q ^b   Feng, B ^c   Shan, Z ^d   Hu, R ^e   Xing, X ^f   Xue, Y ^g  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Tongji University   (China)

^d CHINA MEDICAL UNIVERSITY   (China)

^e FUDAN UNIVERSITY   (China)

^f PEKING UNION MEDICAL COLLEGE   (China)

^g FIRST MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Insulin; SMBG; Type 2 diabetes

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; CHINESE DRUG; GLINIDE DERIVATIVE; GLITAZONE DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CHINA; CHINESE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN TREATMENT; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PROSPECTIVE STUDY; QUESTIONNAIRE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; ANALYSIS; BLOOD; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 2; DOSE RESPONSE; FOLLOW UP; GLUCOSE BLOOD LEVEL; MIDDLE AGED; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; UTILIZATION; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84957831620     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2015.08.005     Document Type: Article

References (24)

1. Guariguata L., Whiting D.R., Hambleton I., Beagley J., Linnenkamp U., Shaw J.E. Global estimates of diabetes prevalence in adults for 2013 and projections for 2035. Diabetes Res Clin Pract 2014, 103(2):137-149.
2. China Diabetes Society China guideline for type 2 diabetes. Chin J Diabetes 2010, 20(1):S1-S6.
3. Ji L., Lu Ju, Guo Xiao, Yang Wen, Wen Jian, Jia Wei, et al. Status of blood glucose control and treatment of type 2 diabetes in China. Chin J Diabetes Mellitus 2012, 4(7):397-401.
4. Xu Y., Wang L., He J., Bi Y., Li M., Wang T., et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013, 310:948-959.
5. Liu Z., Fu C., Wang W., Xu B. Prevalence of chronic complications of type 2 diabetes mellitus in outpatients-cross-sectional hospital based survey in urban China. Health Qual Life Outcomes 2010, 26(8):62. 10.1186/1477-7525-8-62.
6. Lu J., Ji L., Guo Xiao, Gu Wei Glycemic and HbA1c controls of T2DM patients treated with human insulin in China. Chin J Diabetes 2013, 21(9):803-806.
7. Zhou Y., Liao L., Sun M., He G. Self-care practices of Chinese individuals with diabetes. Exper Ther Med 2013, 5:1137-1142.
8. Duran A., Martin P., Runkle I., Perez N., Abad R., Fernandez M., et al. Benefits of self-monitoring blood glucose in the management of new-onset type 2 diabetes mellitus: the St Carlos study, a prospective randomized clinic-based interventional study with parallel groups. J Diabetes 2010, 2:203-211.
9. Polonsky W.H., Fisher L., Schikman C.H., Hinnen D.A., Parkin C.G., Jelsovsky Z., et al. Structured self-monitoring of blood glucose significantly reduces a1c levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the structured testing program study. Diabetes Care 2011, 34:262-267.
10. Polonsky W.H., Fisher L., SchikmanCH, Hinnen DlA, ParkinCG, Jelsovsky Z., et al. A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: results from the STeP study. Diabetes Technol Ther 2011, 13. 10.1089/dia.2011.0073.
11. Bonomo K., De Salve A., Fiora E., Mularoni E., Massucco P., Poy P., et al. Evaluation of a simple policy for pre- and post-prandial blood glucose self-monitoring in people with type 2 diabetes not on insulin. Diabetes Res Clin Pract 2010, 87:246-251.
12. Kempf K., Kruse J., Martin S. Rosso-in-praxi: a self-monitoring of blood glucose-structured 12-week lifestyle intervention significantly improves glucometabolic control of patients with type 2 diabetes mellitus. Diabetes Technol Ther 2010, 12:547-553.
13. Franciosi M., Lucisano G., Pellegrini F., Cantarello A., Consoli A., Cucco L., et al. Roses: Role of self-monitoring of blood glucose and intensive education in patients with type 2 diabetes not receiving insulin. A pilot randomized clinical trial. Diabet Med 2011, 28(7):789-796.
14. Mohan V., Ravikumar R., Poongothai S., Amutha A., Sowmya S., Karkhuzali K., et al. A single-center, open, comparative study of the effect of using self-monitoring of blood glucose to guide therapy on preclinical atherosclerotic markers in type 2 diabetic subjects. J Diabetes Sci Technol 2010, 4:942-948.
15. Shiraiwa T., Takahara M., Kaneto H., Miyatsuka T., Yamamoto K., Yoshiuchi K., et al. Efficacy of occasional self-monitoring of postprandial blood glucose levels in type 2 diabetic patients without insulin therapy. Diabetes Res Clin Pract 2010, 90:e91-e92.
16. Kato N.C., Kato M. Structured self-monitoring of blood glucose reduces glycated hemoglobin in insulin-treated diabetes. J Diabetes Invest 2013, 4:450.
17. China Diabetes Society China Guideline for type 2 diabetes. China Diabetes Soc J 2011, 3(1):13-21. [Chinese].
18. American Diabetes Association Standards of medical care in diabetes-2014. Diabetes Care 2014, 37(Suppl 1):S14-S80.
19. Mohammad E.K., Majid A., Mojtaba M., Gita S., Hamid B. Effects of a structured self-monitoring of blood glucose method on patient self-management behaviour and metabolic outcomes in type 2 diabetes mellitus. J Diabetes Sci Technol 2011, 5(2):388-393.
20. World Medical Association Declaration of Helsinki Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997, 277:925-926.
21. Ji L.N., Lu J.M., Guo X.H., Yang W.Y., Weng J.P., Jia W.P., et al. Glycemic control among patients in china with type 2 diabetes mellitus receiving oral drugs or injectables. BMC Public Health 2013, 13:602.
22. Bergenstal R.M., Gavin J.R. The role of self-monitoring blood glucose in the care of people with diabetes: report of a global consensus conference. Am J Med 2005, 118(Suppl. 9A):1S-6S. Global Consensus Conference on Glucose Monitoring Panel.
23. Tisnado D.M., Adams J.L., Liu H., Damberg C.L., Chen W.P., Hu F.A., et al. What is the concordance between the medical record and patient self-report as data sources for ambulatory care?. Med Care 2006, 44:132-140.
24. Skinner K.M., Miller D.R., Lincoln E., Lee A., Kazis L.E. Concordance between respondent self-reports and medical records for chronic conditions: experience from the Veterans Health Study. J Ambul Care Manage 2005, 28:102-110.